Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

Treatment of acute myeloid leukemia (AML) has improved in recent years and several new therapeutic options have been approved. Most of them include mutation-specific approaches (e.g., gilteritinib for AML patients with activating <i>FLT3</i> mutations), or are restricted to such defined...

Full description

Bibliographic Details
Main Authors: Maximilian Fleischmann, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
AML
targeted therapy
clinical trial
resistance
Online Access:https://www.mdpi.com/2072-6694/13/22/5722

Similar Items

Similar Items